Cargando…
Identification of novel leads as potent inhibitors of HDAC3 using ligand-based pharmacophore modeling and MD simulation
In the landscape of epigenetic regulation, histone deacetylase 3 (HDAC3) has emerged as a prominent therapeutic target for the design and development of candidate drugs against various types of cancers and other human disorders. Herein, we have performed ligand-based pharmacophore modeling, virtual...
Autores principales: | Kumbhar, Navanath, Nimal, Snehal, Barale, Sagar, Kamble, Subodh, Bavi, Rohit, Sonawane, Kailas, Gacche, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810932/ https://www.ncbi.nlm.nih.gov/pubmed/35110603 http://dx.doi.org/10.1038/s41598-022-05698-7 |
Ejemplares similares
-
Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators
por: Kumbhar, Navanath, et al.
Publicado: (2023) -
MD simulation studies to investigate iso-energetic conformational behaviour of modified nucleosides m(2)G and m(2)
(2)G present in tRNA
por: Bavi, Rohit S, et al.
Publicado: (2013) -
Purification and characterization of antibacterial surfactin isoforms produced by Bacillus velezensis SK
por: Barale, Sagar S., et al.
Publicado: (2022) -
Ligand Based Pharmacophore Modeling and Virtual Screening Studies to Design Novel HDAC2 Inhibitors
por: Kandakatla, Naresh, et al.
Publicado: (2014) -
Identification of potent HDAC 2 inhibitors using E-pharmacophore modelling, structure-based virtual screening and molecular dynamic simulation
por: Pai, Padmini, et al.
Publicado: (2022)